COPDOld Problems, New Goals, and Novel Treatments

March 27 – 28, 2015UniversitätsklinikumGießen und Marburg,GermanyAn event supported by Novartis Pharmaceuticals

Novartis Pharma AGCH-4002 Basel, Switzerland

Code: XXXPrint Date: March 2015 © 2015 Novartis Pharma AG

COPD Diagnosis and Disease State - Where are we in 2015?

08:45 – 09:00 Conference welcome & introduction Claus Vogelmeier1, Roland Buhl2

09:00 – 09:45 Novel pathogenic mechanisms in COPD Bernd Schmeck1

09:45 – 10:30 Epigenomics: can it help us individualize therapy for COPD?

Michael Kabesch3

10:30 – 10:45 Coffee break

10:45 – 11:30 Systemic comorbidities and their consequences in patients with COPD

Claus Vogelmeier1

11:30 – 12:15 Assessing and managing patients with cardiovascularcomorbidities in clinical practice: lung & heart interaction

Peter Alter1

12:15 – 13:00 Issues in COPD diagnosis and treatment: overlap with asthma

Timm Greulich1

13:00 – 13:45 Lunch

13:45 – 15:30 Visit 1: Skills lab – best-in-class training opportunities Tina Stibane1

Visit 2: Innovation in Emergency “Room” Andreas Jerrentrup1, Andreas Rembert Koczulla1, Christian Reinke1

15:30 – 15:45 Coffee break

15:45 – 16:30 Non-invasive diagnosis and monitoring in airway disorders Andreas Rembert Koczulla1

16:30 – 17:15 Airway imaging and its relation to clinical outcomes Hans-Ulrich Kauczor5

17:15 – 17:30 Questions and answers/Day 1 Wrap-up Claus Vogelmeier1, Roland Buhl2

AgendaMarch 27, 2015

Germany1) Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg2) Pulmonary Department, University Medical Center, Johannes Gutenberg University Mainz3) Hospital Barmherzige Brüder, Regensburg 4) Vectura GmbH, Gemünden-Wohra

5) Thoraxklinik at Heidelberg University Hospital6) Lungenclinic Großhansdorf7) insaf Respiratory Reserach Institute, Wiesbaden

The Netherlands8) Leiden University Medical Center, NL

AgendaMarch 28, 2015

COPD Treatment – Landscape & Opportunities in 2015 and Beyond

08:45 – 08:50 Welcome, Review of Day 1 & Day 2 introduction Claus Vogelmeier1, Roland Buhl2

08:50 – 09:35 Integrating nonpharmacologic interventions into the treatment regimen for patients with COPD

Christian Taube8

09:35 – 10:20 Efficacy and safety of LABA/LAMA combinations Kai-Michael Beeh7

10:20 – 10:50 Inhalation devices: advancing technology and practicalconsiderations

Gerhard Scheuch4

10:50 – 11:10 Coffee break

11:10 – 11:55 Patient-related outcomes in COPD Stephanie Korn2

11:55- 12:40 Do we need ICS for the treatment of COPD and/or canwe get rid of it?

Klaus F. Rabe6

12:40 – 13:30 Lunch

13:30 – 14:30 Visit 3: Research Lab Bernd Schmeck1

Visit 4: Sleep Lab Christian Reinke1

14:30 – 14:40 Coffee Break

14.40 – 15:25 Treating exacerbations in COPD Andreas Rembert Koczulla1

15.25 – 16:10 Patient-tailored therapy in COPD Roland Buhl2

16.10 – 16:20 Questions and answers/Wrap-up Claus Vogelmeier1, Roland Buhl2

16:20 Departures

Germany1) Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg2) Pulmonary Department, University Medical Center, Johannes Gutenberg University Mainz3) Hospital Barmherzige Brüder, Regensburg 4) Vectura GmbH, Gemünden-Wohra

5) Thoraxklinik at Heidelberg University Hospital6) Lungenclinic Großhansdorf7) insaf Respiratory Reserach Institute, Wiesbaden

The Netherlands8) Leiden University Medical Center, NL